TIFFANY SERELL: Open Payments
NPI 1104856079 · FORT COLLINS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$547 in 31 payments from 11 companies in 2025. Trend: 2023 $1,205 · 2024 $1,239 · 2025 $547
Food & beverage: $547
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $160 |
| Organon LLC | 10 | $120 |
| ABBVIE INC. | 3 | $70 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $40 |
| Arcutis Biotherapeutics, Inc. | 2 | $37 |
| UCB, Inc. | 1 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $16 |
Products named: COSENTYX, SKYRIZI, VTAMA, Cabtreo, Zoryve, Bimzelx, Rhapsido, DUPIXENT.
Industry payments across CO — which companies pay providers there.
